11.04.2015 Views

Relationship of Glycemia to Cardiovascular Disease ... - Lipids Online

Relationship of Glycemia to Cardiovascular Disease ... - Lipids Online

Relationship of Glycemia to Cardiovascular Disease ... - Lipids Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TNT Study: Impact <strong>of</strong> Glucometabolic<br />

Characteristics on Risk <strong>of</strong> Major<br />

<strong>Cardiovascular</strong> Events Among All Patients<br />

Patients with Major<br />

<strong>Cardiovascular</strong> Event (%)<br />

16<br />

12<br />

8<br />

4<br />

0<br />

Low<br />

High-Density<br />

Lipoprotein<br />

Characteristic Absent<br />

Characteristic Present<br />

HR = 1.33<br />

HR = 1.30<br />

Fasting<br />

Glucose<br />

100 mg/dL<br />

HR = 1.24 HR = 1.18 HR = 1.48<br />

Body-Mass<br />

Index<br />

28 kg/m 2<br />

Triglycerides<br />

250 mg/dL<br />

Hypertension<br />

TNT = Treating <strong>to</strong> New Targets study<br />

Reprinted from Deedwania P, et al. Lancet. 2006;<br />

368:919–928, with permission from Elsevier.<br />

Slide Source<br />

<strong>Lipids</strong> <strong>Online</strong> Slide Library<br />

www.lipidsonline.org<br />

TNT Study: Impact <strong>of</strong> Glucometabolic Characteristics on Risk <strong>of</strong> Major<br />

<strong>Cardiovascular</strong> Events Among All Patients<br />

The fac<strong>to</strong>rs associated with residual risk are the criteria commonly used <strong>to</strong> make a<br />

diagnosis <strong>of</strong> metabolic syndrome. According <strong>to</strong> the Treating <strong>to</strong> New Targets study,<br />

patients who have low levels <strong>of</strong> high-density lipoprotein, a fasting glucose >100 mg/dL,<br />

obesity, hypertriglyceridemia, and hypertension are placed at risk despite the lowering <strong>of</strong><br />

low-density lipoprotein with high-dose a<strong>to</strong>rvastatin. These 5 fac<strong>to</strong>rs could then represent<br />

additional targets for intervention with the hope that some <strong>of</strong> the residual risk could be<br />

reduced. At present, attention has been directed <strong>to</strong> the possibility that an intervention that<br />

lowers fasting glucose could remove some <strong>of</strong> this residual risk.<br />

Reference:<br />

Deedwania P, Barter P, Carmena R, et al, for the Treating <strong>to</strong> New Targets Investiga<strong>to</strong>rs.<br />

Reduction <strong>of</strong> low-density lipoprotein cholesterol in patients with coronary heart disease<br />

and metabolic syndrome: analysis <strong>of</strong> the Treating <strong>to</strong> New Targets study. Lancet.<br />

2006;368:919-928.<br />

Source: <strong>Lipids</strong> <strong>Online</strong> Slide Library (www.lipidsonline.org) Page 3 <strong>of</strong> 36<br />

© 2009 Baylor College <strong>of</strong> Medicine, Hous<strong>to</strong>n, Texas

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!